価格表

在庫・価格 : 2024年04月28日 04時18分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Visfatin, Intracellular, Human, ELISA Kit (96well) <Nampt, ELISA Kit>
データシート
AG-45A-0008YEK-KI01 KOMアディポジェン ライフ サイエンシーズ
Adipogen Life Sciences
1 kit ¥162,000
(未発注)
追加

在庫・価格 : 2024年04月28日 04時18分 現在

Visfatin, Intracellular, Human, ELISA Kit (96well) <Nampt, ELISA Kit>

  • 商品コード:AG-45A-0008YEK-KI01
  • メーカー:KOM
  • 包装:1kit
  • 価格: ¥162,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Garten A et al. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes. Biochem. Biophys. Res. Commun. 2010 Jan;391(1):376-81
Garten A et al
2010/01/01
PubMed
2 Garten A et al. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes. Biochem. Biophys. Res. Commun. 2010 Jan;391(1):376-81
Garten A et al
2010/01/01
PubMed
3 Garten A et al. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes. Biochem. Biophys. Res. Commun. 2010 Jan;391(1):376-81
Garten A et al
2010/01/01
PubMed
4 Gaddipati R et al. Visceral adipose tissue visfatin in nonalcoholic fatty liver disease. Ann Hepatol ;9(3):266-70
Gaddipati R et al
PubMed
5 Friebe D et al. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia 2011 May;54(5):1200-11
Friebe D et al
2011/01/01
PubMed
6 Bala M et al. In vivo suppression of visfatin by oral glucose uptake: evidence for a novel incretin-like effect by glucagon-like peptide-1 (GLP-1). J Clin Endocrinol Metab 2011 Aug;96(8):2493-501
Bala M et al
2011/01/01
PubMed
7 Xu W et al. CTRP13 Mitigates Abdominal Aortic Aneurysm Formation via NAMPT1. Mol Ther 2021 01;29(1):324-337
Xu W et al
2021/01/01
PubMed
8 Lu Z et al. Cisplatin resistance of NSCLC cells involves upregulation of visfatin through activation of its transcription and stabilization of mRNA. Chem Biol Interact 2022 Jan;351:109705
Lu Z et al
2022/01/01
PubMed
9 Garten A et al. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes. Biochem. Biophys. Res. Commun. 2010 Jan;391(1):376-81
Garten A et al
2010/01/01
PubMed
10 Gaddipati R et al. Visceral adipose tissue visfatin in nonalcoholic fatty liver disease. Ann Hepatol ;9(3):266-70
Gaddipati R et al
PubMed
11 Friebe D et al. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia 2011 May;54(5):1200-11
Friebe D et al
2011/01/01
PubMed
12 Bala M et al. In vivo suppression of visfatin by oral glucose uptake: evidence for a novel incretin-like effect by glucagon-like peptide-1 (GLP-1). J Clin Endocrinol Metab 2011 Aug;96(8):2493-501
Bala M et al
2011/01/01
PubMed
13 Xu W et al. CTRP13 Mitigates Abdominal Aortic Aneurysm Formation via NAMPT1. Mol Ther 2021 01;29(1):324-337
Xu W et al
2021/01/01
PubMed
14 Lu Z et al. Cisplatin resistance of NSCLC cells involves upregulation of visfatin through activation of its transcription and stabilization of mRNA. Chem Biol Interact 2022 Jan;351:109705
Lu Z et al
2022/01/01
PubMed
  • No.: 1
  • 文献情報:
    Garten A et al. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes. Biochem. Biophys. Res. Commun. 2010 Jan;391(1):376-81
    Garten A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Garten A et al. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes. Biochem. Biophys. Res. Commun. 2010 Jan;391(1):376-81
    Garten A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Garten A et al. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes. Biochem. Biophys. Res. Commun. 2010 Jan;391(1):376-81
    Garten A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Gaddipati R et al. Visceral adipose tissue visfatin in nonalcoholic fatty liver disease. Ann Hepatol ;9(3):266-70
    Gaddipati R et al
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Friebe D et al. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia 2011 May;54(5):1200-11
    Friebe D et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Bala M et al. In vivo suppression of visfatin by oral glucose uptake: evidence for a novel incretin-like effect by glucagon-like peptide-1 (GLP-1). J Clin Endocrinol Metab 2011 Aug;96(8):2493-501
    Bala M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Xu W et al. CTRP13 Mitigates Abdominal Aortic Aneurysm Formation via NAMPT1. Mol Ther 2021 01;29(1):324-337
    Xu W et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Lu Z et al. Cisplatin resistance of NSCLC cells involves upregulation of visfatin through activation of its transcription and stabilization of mRNA. Chem Biol Interact 2022 Jan;351:109705
    Lu Z et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Garten A et al. Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes. Biochem. Biophys. Res. Commun. 2010 Jan;391(1):376-81
    Garten A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Gaddipati R et al. Visceral adipose tissue visfatin in nonalcoholic fatty liver disease. Ann Hepatol ;9(3):266-70
    Gaddipati R et al
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Friebe D et al. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia 2011 May;54(5):1200-11
    Friebe D et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Bala M et al. In vivo suppression of visfatin by oral glucose uptake: evidence for a novel incretin-like effect by glucagon-like peptide-1 (GLP-1). J Clin Endocrinol Metab 2011 Aug;96(8):2493-501
    Bala M et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Xu W et al. CTRP13 Mitigates Abdominal Aortic Aneurysm Formation via NAMPT1. Mol Ther 2021 01;29(1):324-337
    Xu W et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Lu Z et al. Cisplatin resistance of NSCLC cells involves upregulation of visfatin through activation of its transcription and stabilization of mRNA. Chem Biol Interact 2022 Jan;351:109705
    Lu Z et al
    2022/01/01
  • 備考:
  • 参照:
    PubMed